Janney Montgomery Scott’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.98M Buy
47,404
+4,958
+12% +$345K 0.01% 1085
2025
Q4
$2.82M Sell
42,446
-14,865
-26% -$961K 0.01% 1173
2025
Q3
$3.86M Buy
57,311
+14,244
+33% +$1.13M 0.01% 996
2025
Q2
$3.76M Sell
43,067
-195,357
-82% -$15.3M 0.01% 925
2025
Q1
$16.3M Buy
238,424
+5,881
+3% +$480K 0.05% 385
2024
Q4
$18.1M Buy
232,543
+222,548
+2,227% +$16.5M 0.05% 368
2024
Q3
$670K Sell
9,995
-13,060
-57% -$1.07M ﹤0.01% 1766
2024
Q2
$2.61M Sell
23,055
-5,804
-20% -$734K 0.01% 972
2024
Q1
$4M Sell
28,859
-3,012
-9% -$379K 0.01% 840
2023
Q4
$3.95M Sell
31,871
-4,294
-12% -$439K 0.01% 817
2023
Q3
$3.37M Sell
36,165
-21,505
-37% -$2.42M 0.01% 817
2023
Q2
$7.41M Buy
57,670
+13,061
+29% +$1.58M 0.03% 558
2023
Q1
$5.18M Sell
44,609
-1,233
-3% -$138K 0.02% 632
2022
Q4
$5.19M Buy
45,842
+10,597
+30% +$1.16M 0.02% 661
2022
Q3
$2.84M Sell
35,245
-927
-3% -$78.5K 0.01% 820
2022
Q2
$2.7M Buy
36,172
+2,708
+8% +$247K 0.01% 804
2022
Q1
$4.28M Buy
33,464
+3,028
+10% +$331K 0.02% 640
2021
Q4
$4.09M Buy
30,436
+1,392
+5% +$200K 0.02% 686
2021
Q3
$3.97M Buy
29,044
+1,528
+6% +$193K 0.02% 682
2021
Q2
$2.94M Buy
27,516
+16,556
+151% +$1.59M 0.01% 778
2021
Q1
$985K Sell
10,960
-9,704
-47% -$911K ﹤0.01% 1195
2020
Q4
$1.91M Sell
20,664
-50,996
-71% -$4.55M 0.01% 892
2020
Q3
$7.38M Sell
71,660
-3,356
-4% -$351K 0.04% 368
2020
Q2
$7.6M Buy
75,016
+41,460
+124% +$3.71M 0.05% 334
2020
Q1
$2.26M Sell
33,556
-11,932
-26% -$742K 0.02% 652
2019
Q4
$2.49M Sell
45,488
-1,408
-3% -$66.8K 0.02% 706
2019
Q3
$1.75M Sell
46,896
-2,544
-5% -$98.8K 0.01% 819
2019
Q2
$1.85M Buy
49,440
+9,428
+24% +$296K 0.01% 769
2019
Q1
$1.19M Buy
40,012
+16,880
+73% +$593K 0.01% 933
2018
Q4
$693K Buy
23,132
+5,884
+34% +$187K 0.01% 1116
2018
Q3
$617K Sell
17,248
-172
-1% -$5.33K 0.01% 1333
2018
Q2
$414K Sell
17,420
-1,980
-10% -$42K ﹤0.01% 1491
2018
Q1
$360K Buy
19,400
+1,600
+9% +$23.7K ﹤0.01% 1511
2017
Q4
$255K Buy
+17,800
New +$231K ﹤0.01% 1678
2017
Q3
Sell
-11,836
Closed -$216K 1834
2017
Q2
$216K Buy
11,836
+1,000
+9% +$18.5K ﹤0.01% 1590
2017
Q1
$230K Sell
10,836
-3,144
-22% -$61.4K ﹤0.01% 1546
2016
Q4
$209K Sell
13,980
-432
-3% -$7.65K ﹤0.01% 1527
2016
Q3
$316K Sell
14,412
-9,148
-39% -$204K 0.01% 1168
2016
Q2
$468K Buy
+23,560
New +$401K 0.01% 548
2016
Q1
Sell
-10,068
Closed -$206K 1302
2015
Q4
$206K Buy
10,068
+468
+5% +$9.74K 0.01% 1220
2015
Q3
$206K Buy
+9,600
New +$214K 0.01% 1240

Other funds holding DXCM

Janney Montgomery Scott's DXCM Position: Q1 2026 in Review

Janney Montgomery Scott increased its DexCom (DXCM) stake by 12% in Q1 2026, buying an estimated $345K and bringing the position to 47,404 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #1085.

Janney Montgomery Scott first reported a position in DXCM in Q3 2015 and has held it in 41 quarters since. The position peaked at $18.1M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Janney Montgomery Scott held 47,404 shares of DexCom worth $2.98M as of Q1 2026.
  • Janney Montgomery Scott bought 4,958 DexCom shares in Q1 2026, an estimated $345K.
  • DexCom made up 0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1085 holding.
  • Janney Montgomery Scott first reported a position in DexCom in Q3 2015 and has held it in 41 quarters since.
  • Janney Montgomery Scott's DexCom position peaked at $18.1M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.